Product Information
FANAPT 12 MG TABLET is a brand product labeled by Vanda Pharmaceuticals Inc., priced at $60.0099 per EA under NDC 43068011202. Its NADAC has been published 498 times since Mar 1, 2017.
FDA first approved this application on May 6, 2009.
Strength
12 mg/1
Manufacturer
Vanda Pharmaceuticals Inc.NDC
43068011202
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ILOPERIDONEApproval Type
New Drug (NDA)
FDA Application
NDA022192FDA Approved
5/6/2009
On Market Since
10/15/2016
Pharmacological Classes
Price Statistics
The NADAC for FANAPT 12 MG TABLET has been published 498 times since Mar 1, 2017, and over the history we have for it it has risen 88.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $60.0099 per EA |
|---|---|
| All-time high | $60.1123 (Jun 10, 2026) |
| All-time low | $31.7207 (Jun 21, 2017) |
| 52-week high | $60.1123 |
| 52-week low | $57.8003 |
| Median price | $50.8242 |
| Average price | $47.4615 |
| Largest weekly change | +9.0% (Sep 23, 2020) |
| Weeks tracked | 498 |
| Tracking since | Mar 1, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ILOPERIDONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Vanda Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ILOPERIDONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FANAPT 12 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FANAPT 12 MG TABLET, manufactured by Vanda Pharmaceuticals Inc., is $60.0099 per EA (NDC 43068011202), effective Sep 30, 2026.
How has the price of FANAPT 12 MG TABLET changed over time?
Over the history we have for it, the NADAC for FANAPT 12 MG TABLET has risen 88.8%. It has been tracked across 498 weekly CMS publications since Mar 1, 2017.
What are the highest and lowest recorded NADAC prices for FANAPT 12 MG TABLET?
Since Mar 1, 2017, the NADAC for FANAPT 12 MG TABLET has ranged from a low of $31.7207 (Jun 21, 2017) to a high of $60.1123 (Jun 10, 2026), with a median of $50.8242 per EA.
Are there cheaper alternatives to FANAPT 12 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FANAPT 12 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FANAPT 12 MG TABLET?
FANAPT 12 MG TABLET (NDC 43068011202) is labeled by Vanda Pharmaceuticals Inc., and CMS classifies it as a brand product.